3-142724678-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001251845.2(TRPC1):āc.119T>Gā(p.Val40Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000249 in 1,609,448 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 32)
Exomes š: 0.0000021 ( 0 hom. )
Consequence
TRPC1
NM_001251845.2 missense
NM_001251845.2 missense
Scores
3
9
7
Clinical Significance
Conservation
PhyloP100: 6.33
Genes affected
TRPC1 (HGNC:12333): (transient receptor potential cation channel subfamily C member 1) The protein encoded by this gene is a membrane protein that can form a non-selective channel permeable to calcium and other cations. The encoded protein appears to be induced to form channels by a receptor tyrosine kinase-activated phosphatidylinositol second messenger system and also by depletion of intracellular calcium stores. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.36358017).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPC1 | NM_001251845.2 | c.119T>G | p.Val40Gly | missense_variant | 1/13 | ENST00000476941.6 | NP_001238774.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPC1 | ENST00000476941.6 | c.119T>G | p.Val40Gly | missense_variant | 1/13 | 1 | NM_001251845.2 | ENSP00000419313 | P1 | |
TRPC1 | ENST00000273482.10 | c.119T>G | p.Val40Gly | missense_variant | 1/12 | 1 | ENSP00000273482 | |||
TRPC1 | ENST00000698238.1 | c.428T>G | p.Val143Gly | missense_variant | 1/13 | ENSP00000513620 | ||||
TRPC1 | ENST00000460401.1 | c.116T>G | p.Val39Gly | missense_variant, NMD_transcript_variant | 1/3 | 3 | ENSP00000418708 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151620Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151620
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248012Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134192
GnomAD3 exomes
AF:
AC:
3
AN:
248012
Hom.:
AF XY:
AC XY:
1
AN XY:
134192
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1457710Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 725178
GnomAD4 exome
AF:
AC:
3
AN:
1457710
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
725178
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151738Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74172
GnomAD4 genome
AF:
AC:
1
AN:
151738
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74172
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.119T>G (p.V40G) alteration is located in exon 1 (coding exon 1) of the TRPC1 gene. This alteration results from a T to G substitution at nucleotide position 119, causing the valine (V) at amino acid position 40 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;.;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;L;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Uncertain
Sift
Uncertain
D;D;.
Sift4G
Uncertain
D;D;D
Polyphen
D;P;P
Vest4
MutPred
Loss of stability (P = 0.008);Loss of stability (P = 0.008);Loss of stability (P = 0.008);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at